Bridges Investment Management Inc. purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 5,245 shares of the company’s stock, valued at approximately $276,000.
A number of other institutional investors have also modified their holdings of the stock. Principal Securities Inc. acquired a new stake in Azenta during the fourth quarter worth about $36,000. Hantz Financial Services Inc. acquired a new stake in shares of Azenta during the 2nd quarter worth approximately $30,000. Benjamin F. Edwards & Company Inc. purchased a new position in shares of Azenta during the 1st quarter valued at approximately $38,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Azenta in the 1st quarter valued at $49,000. Finally, Lazard Asset Management LLC purchased a new stake in Azenta during the first quarter worth $130,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Azenta Stock Down 0.5 %
AZTA opened at $49.27 on Monday. The firm’s fifty day simple moving average is $52.36 and its two-hundred day simple moving average is $53.85. Azenta, Inc. has a 52-week low of $44.00 and a 52-week high of $69.16. The company has a market cap of $2.66 billion, a price-to-earnings ratio of -18.18 and a beta of 1.47.
Analyst Ratings Changes
AZTA has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $69.00 price objective on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI lifted their price target on Azenta from $52.00 to $53.00 and gave the company an “in-line” rating in a research note on Tuesday, July 2nd. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $67.00.
Check Out Our Latest Research Report on Azenta
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- What to Know About Investing in Penny Stocks
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- How to Evaluate a Stock Before Buying
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.